Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.
about
Genetically modified proteins: functional improvement and chimeragenesisPresentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages.Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells.Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.Efficient Surface Display of Diisopropylfluorophosphatase (DFPase) in E. coli for Biodegradation of Toxic Organophosphorus Compounds (DFP and Cp).Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice.
P2860
Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@en
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@nl
type
label
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@en
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@nl
prefLabel
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@en
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@nl
P2093
P2860
P1433
P1476
Designing a recombinant chimer ...... r prediagnostic breast cancer.
@en
P2093
Ali Hatef Salmanian
Elaheh Gheybi
Farhad Mashayekhi
Samaneh Khodi
P2860
P2888
P304
11489-11497
P356
10.1007/S13277-014-2483-Y
P50
P577
2014-08-16T00:00:00Z